We help Support at Home-approved families find care.
Aged Care Home
Support at Home
Retirement Living
Finance & Placement Advice
Healthcare Equipment
Mobility and Equipment
Patient care equipment
Skin and wound Care
Safety and Security
Assessments
Assistive Technology
End of Life
Financial Services
Funerals
Placement Consultants
Advocacy
No results found
No results found
No results found
Advanced Filters
Distance (proximity)
Price Range
RAD (Refundable Accommodation Deposit) is a lump-sum payment for aged care homes. It is fully refundable when the resident leaves, as long as there are no outstanding fees.
Min RAD
Any
$250,000
$500,000
$750,000
$1,000,000
$1,500,000
$1,750,000
$2,000,000
Maximum RAD
Any
$250,000
$500,000
$750,000
$1,000,000
$1,500,000
$1,750,000
$2,000,000
Facility size
Based on how many beds the facilty has.
Any
Small
Medium
Large
Service Delivery
Services offered at a location or in a region
Any
On Site
Service Region
Features
Single rooms with ensuites
Respite beds
Extra service beds
Secure dementia beds
24/7 Registered nursing
Full or Partially government funded
Couples accommodation
Facility has pets
Non-dedicated respite
Palliative care
Partner considered without ACAT
Secure garden
Transition care
Cafe/Kiosk
Chapel/Church
Hairdressing Salon
Facility Owned Transport
Single Rooms
Rooms with ensuites
Registered nursing
Non secure dementia care
Diversional therapy
Medication supervision
Respite care
Secure access
Small pets considered

‘Spicing up’ dementia research

An ingredient in curry spice, testosterone supplements and retinal scans are reportedly tools being used by West Australian researchers to help battle, prevent or detect memory loss. Such cognitive loss as dementia, and the progressive decline in the ability to think and learn, will affect almost one million people by 2050.

Posted
by Rex Facts

An ingredient in curry spice, testosterone supplements and retinal scans are reportedly tools being used by West Australian researchers to help battle, prevent or detect memory loss.

Such cognitive loss as dementia, and the progressive decline in the ability to think and learn, will affect almost one million people by 2050, according to Alzheimer’s Australia – with the cost topping $80 billion by 2063.

McCusker Alzheimer’s Research Foundation director, Ralph Martins, says a world-first trial would involve the ingestion of curcumin – an ingredient of the curry spice turmeric – and a powerful antioxidant that attacks beta-amyloid in the brain.

Beta-amyloid, a small protein, is believed to be the culprit in the onset of dementia by killing neurons and preventing them from setting down new memories.

In the study – to be conducted jointly with a US group – patients will be given a curcumin ‘pudding’ to eat over three to four days.

Curcumin binds to amyloid and the build-up can be detected in the retina, with a simple scan showing if the levels are indicative of pre-Alzheimer’s.

Brain scans will be used to validate the retinal findings.

Early diagnosis will enable prevention strategies to be swung into place for patients well before the brain is severely damaged.

The McCusker Foundation has received major funding for the trial – the first of its kind in the world – from the WA government, the federal government Cooperative Research Centres for Mental Health and private donors.

“The evidence is clearly showing now through our large Australian Imaging, Biomarker and Lifestyle (AIBL) Study of Ageing that people who have got low testosterone have high levels of amyloid in their brain,” Professor Martins said.

“The ultimate question is: if you give them testosterone, can you bring amyloid down and can you prevent the onset of dementia and preserve memories?”

A preliminary study in Indonesia – designed and supervised by Professor Martins and his team at ECU – has shown a lot of promise for testosterone as a treatment.

Read next

Sign up or log in with your phone number
Phone
Enter your phone number to receive a verification notification
Aged Care Guide is endorsed by
COTA logo
ACIA logo